Back to News
investment

Texas Capital Bancshares Board Director Buys 40K Shares for $888K

The Motley Fool
Loading...
4 min read
0 likes
⚡ Quantum Brief
A Texas Capital Bancshares board director purchased 40,000 depositary shares (TCBIO) for $888,000 at $22.20 per share on February 23–24, 2026, increasing his direct holdings by 11.76%. The transaction involved Series B Preferred depositary shares (TCBIO), not common stock (TCBI), offering dividends but no voting rights. Each TCBIO represents 1/40th of a Series B share. The purchase follows Texas Capital’s announcement of a $14.38 per Series B share dividend (payable March 16, 2026), equating to $0.36 per TCBIO share. Common stock (TCBI) has risen 21.94% over the past year, though recent quarterly revenue and net income declined. The company’s Texas-focused operations limit geographic diversification. TCBIO provides dividend exposure in the banking sector, contrasting with non-dividend-paying TCBI, which offers voting rights and a 5% gain in 2026.
AI Audio Summary
0:00 / 0:00
Click to play
Texas Capital Bancshares Board Director Buys 40K Shares for $888K

Summarize this article with:

By Adé Hennis – Mar 2, 2026 at 2:35AM ESTKey PointsRobert W. Stallings purchased 40,000 depositary shares for a total transaction value of approximately $888,000, based on the SEC Form 4 weighted average price of $22.20 per share.This acquisition represented 11.76% of Stallings’s total reported holdings prior to the transaction. Robert W. Stallings, a director at Texas Capital Bancshares (TCBI 6.21%), a major Texas-based commercial lender, reported the purchase of 40,000 shares of Depositary Shares for Series B Preferred shares through multiple transactions on Feb. 23 and Feb. 24, 2026, as disclosed in a SEC Form 4 filing. Transaction summaryMetricValueShares traded40,000Transaction value~$888,000Post-transaction shares (direct)289,961Post-transaction shares (indirect)90,039Post-transaction value (direct ownership)~$28.05 millionTransaction value based on SEC Form 4 weighted average purchase price ($22.20); post-transaction value based on the weighted average closing price between the two days of the transaction. Key questionsWere any options or derivatives exercised, or was this a straightforward open-market purchase?No derivative instruments or option exercises were reported; the transaction consisted entirely of open-market acquisitions of Depositary Shares for Series B Preferred shares.What is the market context around this transaction?The purchase was made at a weighted average price of $22.20 per share. The stock has delivered a 29.88% total return over the trailing year. ExpandNASDAQ: TCBITexas Capital BancsharesToday's Change(-6.21%) $-6.30Current Price$95.20Key Data PointsMarket Cap$4.2BDay's Range$94.12 - $100.8152wk Range$59.37 - $108.92Volume31KAvg Vol475KCompany overviewMetricValueRevenue (TTM)$1.20BNet income (TTM)$312.99M1-year price change21.94%* 1-year performance is calculated using Feb. 28, 2026 as the reference date. Company snapshotTexas Capital Bancshares is a leading regional bank holding company headquartered in Dallas, Texas, with a strong presence across the state. The company offers a comprehensive suite of commercial and consumer banking products, including deposit accounts, commercial and real estate loans, mortgage finance, equipment leasing, and wealth management services. It generates revenue primarily through net interest income on loans and deposits, as well as fee-based services such as investment banking, escrow, and trust operations.What this transaction means for investorsIt’s important to note that Stallings actually didn’t purchase any TCBI shares, nor did he purchase Series B preferred stock. He purchased the company’s Depositary Shares, known as TCBIO. Each TCBIO share equals 1/40 of an ownership interest in one Series B preferred share. TCBIO offers investors to earn dividends from Texas Capital Bancshares, but has no voting power. The common stock, TCBI, pays zero dividends but offers voting power. In late January 2026, Texas Capital announced it would pay a cash dividend of $14.38 per Series B share, equivalent to $0.359375 per depositary share. The dividend will be paid on March 16 for those who hold shares by the end of the business day on March 2. Those interested in investing in the holding company’s depositary shares can find it listed on the NASDAQ under the ticker TCBIO. Texas Capital’s common stock has generated a positive return for three consecutive years, and share prices are currently up around 5% in 2026. However, the company’s financials have fluctuated in previous quarters, and in its most recent Q4 of FY 2025, its revenue and net income fell from the previous quarter. There’s also the concern that the company is limited in its operational focus on Texas. That said, TCBIO remains an option for those looking for dividend exposure in the banking sector. Read NextFeb 24, 2026 •By Jack DelaneyTexas Capital Bancshares Could Soar If These 2 Things Go RightJul 21, 2022 •By Motley Fool TranscribingTexas Capital Bancshares (TCBI) Q2 2022 Earnings Call TranscriptJan 21, 2022 •By Motley Fool TranscribingTexas Capital Bancshares (TCBI) Q4 2021 Earnings Call TranscriptSep 2, 2021 •By Bram BerkowitzWhy Shares of Texas Capital Bancshares Are Falling TodayJul 21, 2021 •By Motley Fool TranscribersTexas Capital Bancshares, inc (TCBI) Q2 2021 Earnings Call TranscriptApr 21, 2021 •By Motley Fool TranscribersTexas Capital Bancshares Inc (TCBI) Q1 2021 Earnings Call TranscriptStocks MentionedTexas Capital BancsharesNASDAQ: TCBI$95.20(-6.21%)-$6.30*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Read Original

Tags

quantum-investment

Source Information

Source: The Motley Fool